Data in Biotech
Data in Biotech brings data leaders from across biotech, pharma, and life sciences into honest conversations about how their organizations actually use data. Host Ross Katz talks with directors, VPs, and heads of data about the real challenges: building data cultures in regulated environments, scaling analytics teams, and turning experimental data into business decisions. Over 58 episodes, the show has featured leaders from companies like Lyell Immunopharma, Recursion, and Tempus.
Hosted by Ross Katz
Show Details
Episodes
Page 2 of 4
Automating Biopharma Knowledge Work with Convoke
with Alex Telford, Co-Founder and CEO at Convoke & Maged Ahmed, Co-Founder at Convoke
Alex Telford and Maged Ahmed of Convoke discuss how AI-native workflows automate clinical trial design and regulatory writing in biopharma.
How Eli Lilly's TuneLab Codevelops AI Models with Biotech
with Dr. Aliza Apple, VP of Catalyze360 AI/ML at Eli Lilly
Dr. Aliza Apple unveils TuneLab, Eli Lilly's federated learning platform that lets biotech partners access billion-dollar AI models without sharing raw data.
Inside Merck's Computational Biology with Jesper Ryge
with Jesper Ryge, Director of Computational Biology at Merck
Jesper Ryge, Director of Computational Biology at Merck, discusses multi-omics, spatial transcriptomics, and bridging experimental biology with AI.
Where Biotech Innovation Really Happens: 50th Special
with Jacob Oppenheim, Venture Partner at RA Capital & Wolfgang Halter, Director of Data Science at Merck & Dave Johnson, Founder and CEO at Dash Bio
Three returning guests — Oppenheim, Halter, and Johnson — join Ross Katz for a milestone retrospective on AI trust, innovation, and industry myths.
How BioRaptor Is Modernizing Bioprocessing Workflows
with Yaron David, CTO and Co-Founder at BioRaptor
Yaron David discusses how BioRaptor replaces black-box systems and tribal knowledge in bioprocessing with transparent, modern data workflows.
Modernizing Clinical Data Analysis with Jesse Paquette
with Jesse Paquette, Co-founder and CSO at Tag.bio
Jesse Paquette of Tag.bio explains how data mesh and FAIR principles make clinical data reusable and actionable without needing a data science degree.
Scalable Data Platforms for Spatial Biology with LatchBio
with Kenny Workman, Co-founder at LatchBio
Kenny Workman of LatchBio shares how his team built a scientific computing platform from scratch and why spatial assays are rewriting bioinformatics rules.
Solving Chronic Disease with Life Insurance and Data
with Jeremy Shane, Founder at Life for Health
Jeremy Shane explains how combining life insurance, longitudinal data, and patient engagement creates a new model for chronic disease management.
How Etiome Is Redefining Preemptive Medicine
with Scott Lipnick, Co-Founder and President at Etiome
Scott Lipnick of Etiome discusses using AI to anticipate disease progression and deliver targeted interventions before symptoms appear.
Transforming Houseplants with Synthetic Biology
with Patrick Torbey, CEO and Co-Founder at Neoplants
Patrick Torbey of Neoplants explains how genetic engineering and microbiome innovation are turning houseplants into air purifiers.
How Phage Therapy Is Scaling to Meet Antibiotic Resistance
with Jessica Sacher, Co-Founder, Phage Directory; Staff Scientist at Stanford
Jessica Sacher discusses sourcing phages, operationalizing therapy, and predicting efficacy through data to combat antibiotic resistance.
Targeting Transcription Factors with AI at Talus Bio
with William Fondrie, Head of Data Science and Engineering at Talus Bio
William Fondrie of Talus Bio explains how machine learning, mass spectrometry, and computational models are transforming drug discovery.
Decoding the Dark Proteome with Dr. Jonathan Usuka
with Dr. Jonathan Usuka, CEO at Sapient
Dr. Jonathan Usuka discusses the role of proteomics and metabolomics in drug discovery and the opportunity for deeper biological insights.
AI for Clinical Trial Efficiency with Patrick Leung
with Patrick Leung, Chief Technology Officer at Faro Health
Patrick Leung of Faro Health discusses how AI generates clinical trial protocols, reduces inefficiencies, and optimizes patient burden.
Organoids and Active Learning with Naren Tallapragada
with Naren Tallapragada, CEO & Co-Founder at Tessel Bio
Naren Tallapragada of Tessel Bio discusses using organoids and active learning to reverse-engineer chronic disease treatments.
Speeding Up Scientific Breakthroughs with Alex Junge
with Alexander Junge, Co-Founder & CTO at amass
Alexander Junge of amass explains how AI-powered tools help researchers and biotech firms navigate scientific literature faster.
Gene and Cell Therapy Data with Dipen Sangurdekar
with Dipen Sangurdekar, VP of Data Sciences at KSQ Therapeutics
Dipen Sangurdekar of KSQ Therapeutics discusses data-driven therapeutic design in gene and cell therapy using computational biology and ML.
AI for Neglected Disease Therapeutics with Timothy Jenkins
with Timothy Jenkins, Head of Data Science & Associate Professor at DTU Bioengineering
Timothy Jenkins of DTU Bioengineering discusses using AI-guided protein design to democratize therapeutic discovery for neglected diseases.
AI-Driven Drug Discovery with Fred Manby
with Fred Manby, Co-Founder & CTO at Iambic Therapeutics
Fred Manby of Iambic Therapeutics explains how AI platforms and uncertainty quantification are reshaping early-stage drug discovery.
Unlocking the Power of AI in Microscopy
with Ilya Goldberg, Chief Science Officer at ViQi & Reese Findley, AI Data Scientist at ViQi
Ilya Goldberg (CSO) and Reese Findley (AI Data Scientist) of ViQi on applying machine learning to automated brightfield microscopy for life sciences.
Need help with biotech data?
CorrDyn works with life sciences companies to build data infrastructure that accelerates research and operations. The same expertise behind these conversations.
Book an intro callGuest Companies
Data leaders from across the life sciences ecosystem.